Calcium-dependent proteasome activation is required for axonal neurofilament degradation

Neural Regeneration Research

Volumn 8, Issue 36, 2013, Pages 3401-3409

  Park, Joo Youn ^a   Jang, So Young ^a   Shin, Yoon Kyung ^a   Suh, Duk Joon ^a   Park, Hwan Tae ^a  

^a Dong A University College of Medicine   (South Korea)

Author keywords

Axon; Axon degeneration; Calcium; Calpain; Microtubule depolymerization; Mitochondria; Neural regeneration; Neurofilament degradation; Neuroregeneration; Peripheral nerve injury; Sciatic nerve

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALPAIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; PROTEASOME; UBIQUITINATED PROTEIN; CALCIUM; CALPEPTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CHELATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; EXPLANT; EXTRACELLULAR CALCIUM; FEMALE; MORPHOMETRICS; MOUSE; NEUROFILAMENT; NONHUMAN; PROTEIN DEGRADATION; WALLERIAN DEGENERATION; WESTERN BLOTTING; DEPLETION; DEPOLYMERIZATION; ENZYME ACTIVATION; ENZYME ACTIVITY; IMMUNOFLUORESCENCE; MICROTUBULE; MITOCHONDRION SWELLING; NERVE FIBER DEGENERATION;

EID: 84892701048     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2013.36.005     Document Type: Article

References (50)

1. Wang JT, Medress ZA, Barres BA. Axon degeneration: molecular mechanisms of a self-destruction pathway. J Cell Biol. 2012;196:7-18.
2. Court FA, Coleman MP. Mitochondria as a central sensor for axonal degenerative stimuli. Trends Neurosci. 2012; 35:364-372.
3. Yan T, Feng Y, Zhai Q. Axon degeneration: Mechanisms and implications of a distinct program from cell death. Neurochem Int. 2010;56:529-534.
4. Martinelli P, Rugarli EI. Emerging roles of mitochondrial proteases in neurodegeneration. Biochim Biophys Acta. 2010;1797:1-10.
5. Saxena S, Caroni P. Mechanisms of axon degeneration: from development to disease. Prog Neurobiol. 2007;83: 174-191.
6. Conforti L, Adalbert R, Coleman MP. Neuronal death: where does the end begin? Trends Neurosci. 2007;304: 159-166.
7. George EB, Glass JD, Griffin JW. Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J Neurosci. 1995;15:6445-6452.
8. Glass JD, Culver DG, Levey AI, et al. Very early activation of m-calpain in peripheral nerve during Wallerian degeneration. J Neurol Sci. 2002;196:9-20.
9. Ma M. Role of calpains in the injury-induced dysfunction and degeneration of the mammalian axon. Neurobiol Dis. 2013;60:61-79.
10. Ma M, Ferguson TA, Schoch KM, et al. Calpains mediate axonal cytoskeleton disintegration during Wallerian degeneration. Neurobiol Dis. 2013;56:34-46.
11. Kilinc D, Gallo G, Barbee KA. Mechanical membrane injury induces axonal beading through localized activation of calpain. Exp Neurol. 2009;219:553-561.
12. Touma E, Kato S, Fukui K, et al. Calpain-mediated cleavage of collapsin response mediator protein(CRMP)-2 during neurite degeneration in mice. Eur J Neurosci. 2007;26:3368-3381.
13. Huh JW, Franklin MA, Widing AG, et al. Regionally distinct patterns of calpain activation and traumatic axonal injury following contusive brain injury in immature rats. Dev Neurosci. 2006;285:466-476.
14. Thompson SN, Gibson TR, Thompson BM, et al. Relationship of calpain-mediated proteolysis to the expression of axonal and synaptic plasticity markers following traumatic brain injury in mice. Exp Neurol. 2006;201:253-265.
15. Das A, Guyton MK, Smith A, et al. Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats. J Neurochem. 2013;124:133-146.
16. Barrientos SA, Martinez NW, Yoo S, et al. Axonal degeneration is mediated by the mitochondrial permeability transition pore. J Neurosci. 2011;31:966-978.
17. Park JY, Jang SY, Shin YK, et al. Mitochondrial swelling and microtubule depolymerization are associated with energy depletion in axon degeneration. Neuroscience. 2013;238:258-269.
18. Avery MA, Rooney TM, Pandya JD, et al. WldS prevents axon degeneration through increased mitochondrial flux and enhanced mitochondrial Ca2+ buffering. Curr Biol. 2012;22:596-600.
19. Zhai Q, Wang J, Kim A, et al. Involvement of the ubiquitin-proteasome system in the early stages of wallerian degeneration. Neuron. 2003;39:217-225.
20. Gilley J, Coleman MP. Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons. PLoS Biol. 2010;8:e1000300.
21. Wakatsuki S, Saitoh F, Araki T. ZNRF1 promotes Wallerian degeneration by degrading AKT to induce GSK3B-dependent CRMP2 phosphorylation. Nat Cell Biol. 2011;13:1415-1423.
22. Gou JP, Leterrier JF. Possible involvement of ubiquitination in neurofilament degradation. Biochem Biophy Res Comm. 1995;217:529-538.
23. Simonin Y, Ferrer-Alcon M, Ferri A, et al. The neuroprotective effects of the WldS gene are correlated with proteasome expression rather than apoptosis. Eur J Neurosci. 2007;25:2269-2274.
24. Hoopfer ED, McLaughlin T, Watts RJ, et al. Wlds protection distinguishes axon degeneration following injury from naturally occurring developmental pruning. Neuron. 2006;50:883-895.
25. MacInnis BL, Campenot RB. of Wallerian degeneration and nerve growth factor withdrawal-induced pruning of axons of sympathetic neurons by the proteasome and the MEK/Erk pathway. Mol Cell Neurosci. 2005;28:430-439.
26. Korhonen L, Lindholm D. The ubiquitin proteasome system in synaptic and axonal degeneration: a new twist to an old cycle. J Cell Biol. 2004;165:27-30.
27. Ehlers MD. Deconstructing the axon: Wallerian degeneration and the ubiquitin-proteasome system. Trends Neurosci. 2004;27:3-6.
28. Watts RJ, Hoopfer ED, Luo L. Axon pruning during Drosophila metamorphosis: evidence for local degeneration and requirement of the ubiquitin-proteasome system. Neuron. 2003;38:871-885.
29. Shi K, Li J, Han K, Jiang H, et al. The degradation of kinesin-like calmodulin binding protein of D. salina (DsKCBP) is mediated by the ubiquitin-proteasome system. Mol Biol Rep. 2013;40:3113-3121.
30. Jung J, Cai W, Lee HK, et al. Actin polymerization is essential for myelin sheath fragmentation during Wallerian degeneration. J Neurosci. 2011;31:2009-2015.
31. Shin YK, Jang SY, Park JY, et al. The NeuregulinRac-MKK7 pathway regulates antagonistic c-jun/Krox20 expression in Schwann cell dedifferentiation. Glia. 2013; 61:892-904.
32. Lee HK, Shin YK, Jung J, et al. Proteasome inhibition suppresses Schwann cell dedifferentiation in vitro and in vivo. Glia. 2009;57:1825-1834.
33. Samantaray S, Ray SK, Banik NL. Calpain as a potential therapeutic target in Parkinson's disease. CNS Neurol Disord Drug Targets. 2008;7:305-312.
34. Lee DH, Goldberg AL. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 1998;8:397-403.
35. Jung T, Grune T. The proteasome and the degradation of oxidized proteins: Part I-structure of proteasomes. Redox Biol. 2013;1:178-182.
36. Menconi MJ, Wei W, Yang H, et al. Treatment of cultured myotubes with the calcium ionophore A23187 increases proteasome activity via a CaMK II-caspase-calpain-dependent mechanism. Surgery. 2004;136:135-142.
37. Djakovic SN, Schwarz LA, Barylko B, et al. Regulation of the proteasome by neuronal activity and calcium/ calmodulin-dependent protein kinase II. J Biol Chem. 2009; 284:26655-26665.
38. Nayak MK, Kumar K, Dash D. Regulation of proteasome activity in activated human platelets. Cell Calcium. 2011; 49:226-232.
39. Lopez-Picon FR, Kukko-Lukjanov TK, Holopainen IE. The calpain inhibitor MDL-28170 and the AMPA/KA receptor antagonist CNQX inhibit neurofilament degradation and enhance neuronal survival in kainic acid-treated hippocampal slice cultures. Eur J Neurosci. 2006;23:2686-2694.
40. Shaw G, Yang C, Zhang L, et al. Characterization of the bovine neurofilament NF-M protein and cDNA sequence, and identification of in vitro and in vivo calpain cleavage sites. Biochem Biophys Res Commun. 2004;325:619-625.
41. Wang J, Zhai Q, Chen Y, et al. A local mechanism mediates NAD-dependent protection of axon degeneration. J Cell Biol. 2005;170:349-355.
42. Nicholls DG. Mitochondrial calcium function and dysfunction in the central nervous system. Biochim Biophy Acta. 2009;1787:1416-1424.
43. Chang KT, Niescier RF, Min KT. Mitochondrial matrix Ca2+ as an intrinsic signal regulating mitochondrial motility in axons. Proc Natl Acad Sci U S A. 2011;108:15456-15461.
44. Verkhratsky A, Fernyhough P. Mitochondrial malfunction and Ca2+ dyshomeostasis drive neuronal pathology in diabetes. Cell Calcium. 2008;44:112-122.
45. Yoshii SR, Kishi C, Ishihara N, et al. Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane. J Biol Chem. 2011; 286:19630-19640.
46. Geisler S, Holmstrom KM, Skujat D, et al. PINK1/Parkinmediated mitophagy is dependent on VDAC1 and p62/ SQSTM1. Nature Cell Biol. 2010;12:119-131.
47. Bragoszewski P, Gornicka A, Sztolsztener ME, et al. The ubiquitin-proteasome system regulates mitochondrial intermembrane space proteins. Mol Cell Biol. 2013;33: 2136-2148.
48. Leboucher GP, Tsai YC, Yang M, et al. Stress-induced phosphorylation and proteasomal degradation of mitofusin 2 facilitates mitochondrial fragmentation and apoptosis. Mol Cell. 2012;47:547-557.
49. Clarke KJ, Adams AE, Manzke LH, et al. A role for ubiquitinylation and the cytosolic proteasome in turnover of mitochondrial uncoupling protein 1 (UCP1). Biochim Biophys Acta. 2012;1817:1759-1767.
50. Kitay BM, McCormack R, Wang Y, et al. Mislocalization of neuronal mitochondria reveals regulation of Wallerian degeneration and NMNAT/WLDS-mediated axon protection independent of axonal mitochondria. Human Mol Gen. 2013;22:1601-1614.